Search Result

Isoforms Recommended:	ALDH1

Results for "

ALDH1

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Aldehyde Dehydrogenase (ALDH) (32) Apoptosis (8) Chemerin Receptor (1) Cholinesterase (ChE) (1) Cuproptosis (2) Endogenous Metabolite (1) Ferroptosis (1) Interleukin Related (2) Necroptosis (1) PROTACs (1) Pyroptosis (2) Reactive Oxygen Species (1) Small Interfering RNA (siRNA) (8)
By Research Areas:	Cancer (28) Endocrinology (2) Inflammation/Immunology (2) Metabolic Disease (6) Neurological Disease (1)
Oligonucleotides:	Pre-designed siRNA Sets (8) siRNAs (8)

Inhibitors & Agonists

Natural
Products

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-122912

ALDH1A inhibitor 673A ALDH1Ai 673A	Aldehyde Dehydrogenase (ALDH) Necroptosis	Cancer
ALDH1A inhibitor 673A is an *ALDH1A* inhibitor. ALDH1A inhibitor 673A inhibits all three ALDH1A family members (IC₅₀: 246 nM, 230 nM, 348 nM for ALDH1A1, ALDH1A2, ALDH1A3 respectively. ALDH1A inhibitor 673A induces necroptotic cell death preferentially in CD133+ ovarian CSCs. ALDH1A inhibitor 673A also inhibits chemotherapy-resistant tumor growth ^[1].

HY-W017186

ALDH1A3-IN-3	Aldehyde Dehydrogenase (ALDH)	Cancer
ALDH1A3-IN-3 (compound 16) is a potent inhibitor of *ALDH1A3, with an IC₅₀* of 0.26 μM. ALDH1A3-IN-3 is also a good ALDH3A1 substrate. ALDH1A3-IN-3 can be used for the research of prostate cancer ^[1].

HY-144667

ALDH1A3-IN-1	Aldehyde Dehydrogenase (ALDH)	Cancer
ALDH1A3-IN-1 (Compound 14) is a potent *ALDH1A3* inhibitor, with an IC₅₀ of 0.63 µM and a K_i of 0.46 µM. ALDH1A3-IN-1 can be studied in prostate cancer ^[1].

HY-144669

ALDH1A3-IN-2	Aldehyde Dehydrogenase (ALDH)	Cancer
ALDH1A3-IN-2 (Compound 15) is a potent inhibitor of *ALDH1A3* with an IC₅₀ of 1.29 μM. Aldehyde dehydrogenases (ALDHs) are overexpressed in various tumor types including prostate cancer. ALDH1A3-IN-2 has the potential for the research of cancer diseases ^[1].

HY-126003

ALDH1A1-IN-2	Aldehyde Dehydrogenase (ALDH)	Cancer
ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295) ^[1].

HY-139031

ALDH1A2-IN-1	Aldehyde Dehydrogenase (ALDH)	Endocrinology
ALDH1A2-IN-1 is an active site-directed reversible *ALDH1A2* inhibitor (IC₅₀=0.91 μM; Kd=0.26 μM) with several hydrophobic interactions ^[1].

HY-158026

ALDH1A1-IN-5	Aldehyde Dehydrogenase (ALDH)	Cancer
ALDH1A1-IN-5 (compound 25) is a potent aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitor with EC₅₀ value of 83, 45, 43 µM for ALDH1A1, ALDH1A2, ALDH1A3, respectively. ALDH1A1-IN-5 has the potential for the research of high-grade serous ovarian cancer (HGSOC) ^[1].

HY-146240

ALDH1A1-IN-3	Aldehyde Dehydrogenase (ALDH)	Metabolic Disease
ALDH1A1-IN-3 (compound 57) is an excellent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitor with an IC₅₀ value of 0.379 μM. ALDH1A1-IN-3 can effectively improve glucose consumption in HepG2 cells. ALDH1A1-IN-3 can be used for researching glucose metabolism improvement ^[1].

HY-157872

ALDH1A1-IN-4	Aldehyde Dehydrogenase (ALDH)	Cancer
ALDH1A1-IN-4 (compound A1) is a potent inhibitor of aldehyde dehydrogenase (ALDH) A1, with IC₅₀ value of 0.32 μM. ALDH1A1-IN-4 plays an important role in cancer research ^[1].

HY-RS00560

ALDH1A1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ALDH1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1A1 Human Pre-designed siRNA Set A ALDH1A1 Human Pre-designed siRNA Set A

HY-RS00561

Aldh1a1 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Aldh1a1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Aldh1a1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Aldh1a1 Mouse Pre-designed siRNA Set A Aldh1a1 Mouse Pre-designed siRNA Set A

HY-RS00562

ALDH1A1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ALDH1A1 Rat Pre-designed siRNA Set A contains three designed siRNAs for ALDH1A1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1A1 Rat Pre-designed siRNA Set A ALDH1A1 Rat Pre-designed siRNA Set A

HY-RS00563

ALDH1A2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ALDH1A2 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH1A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1A2 Human Pre-designed siRNA Set A ALDH1A2 Human Pre-designed siRNA Set A

HY-RS00564

ALDH1A3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ALDH1A3 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH1A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1A3 Human Pre-designed siRNA Set A ALDH1A3 Human Pre-designed siRNA Set A

HY-RS00566

ALDH1L1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ALDH1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1L1 Human Pre-designed siRNA Set A ALDH1L1 Human Pre-designed siRNA Set A

HY-RS00567

ALDH1L2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ALDH1L2 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH1L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1L2 Human Pre-designed siRNA Set A ALDH1L2 Human Pre-designed siRNA Set A

HY-RS00565

ALDH1B1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ALDH1B1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH1B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1B1 Human Pre-designed siRNA Set A ALDH1B1 Human Pre-designed siRNA Set A

HY-W016645

4-Diethylaminobenzaldehyde 1 Publications Verification	Aldehyde Dehydrogenase (ALDH)	Cancer
4-Diethylaminobenzaldehyde is a reversible aldehyde dehydrogenases (ALDHs) inhibitor, with a K_i of 4 nM for ALDH1. 4-Diethylaminobenzaldehyde displays potent anti-androgenic effect (IC₅₀= 1.71μM) ^[1] .

HY-19801

CVT-10216 1 Publications Verification	Aldehyde Dehydrogenase (ALDH)	Neurological Disease
CVT-10216 is a highly selective, reversible aldehyde dehydrogenase-2 (ALDH-2) inhibitor with an IC₅₀ of 29 nM. CVT-10216 also has inhibitory effect of ALDH-1 with an IC₅₀ of 1.3 μM. CVT-10216 can reduce excessive alcohol drinking in alcohol-preferring rats and exhibit anxiolytic effects ^[1].

HY-148243

IGUANA-1 free base STL5-T-0057	Aldehyde Dehydrogenase (ALDH)	Cancer
IGUANA-1 free base (STL5-T-0057) is an selective ALDH1 B1 inhibitor with an IC₅₀ value of 30 nM. IGUANA-1 free base inhibits cell growth of SW480 cells in adherent and spheroid conditions with IC₅₀ values of 2.46 and 0.39 μM, respectively. IGUANA-1 free base can be used for the research of cancer ^[1].

HY-B0240

Disulfiram Maximum Cited Publications 61 Publications Verification Tetraethylthiuram disulfide; TETD	Aldehyde Dehydrogenase (ALDH) Interleukin Related Pyroptosis Apoptosis Cuproptosis	Metabolic Disease Cancer
Disulfiram (Tetraethylthiuram disulfide) is a specific inhibitor of aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol. Disulfiram inhibits gasdermin D (GSDMD) pore formation in liposomes and inflammasome-mediated pyroptosis and IL-1β secretion in human and mouse cells. Disulfiram, a copper ion carrier, with Cu ²⁺ increases intracellular ROS levels and induces cuproptosis ^[1] .

HY-B0240R

Disulfiram (Standard)	Aldehyde Dehydrogenase (ALDH) Interleukin Related Pyroptosis Apoptosis Cuproptosis	Metabolic Disease Cancer
Disulfiram (Standard) is the analytical standard of Disulfiram. This product is intended for research and analytical applications. Disulfiram (Tetraethylthiuram disulfide) is a specific inhibitor of aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol. Disulfiram inhibits gasdermin D (GSDMD) pore formation in liposomes and inflammasome-mediated pyroptosis and IL-1β secretion in human and mouse cells. Disulfiram + Cu ²⁺ increases intracellular ROS levels triggering apoptosis of ovarian cancer stem cells ^[1-6].

HY-157567

FSI-TN42 N42	Aldehyde Dehydrogenase (ALDH)	Metabolic Disease
ALDH1A1/2-IN-1 is an *ALDH1A1* and *ALDH1A2* inhibitor that can be used for preventing spermatogenesis ^[1].

HY-135841

CM010	Aldehyde Dehydrogenase (ALDH)	Metabolic Disease Cancer
CM010 is a potent and selective *aldehyde dehydrogenase 1A (ALDH1A) family* inhibitor, with IC₅₀s of 1700, 740, and 640 nM for ALDH1A1, ALDH1A2, and ALDH1A3, respectively. CM010 does not inhibit any of the other ALDH family members. CM010 can regulate metabolism and has anti-cancer activity ^[1].

HY-125085

ALDH3A1-IN-3	Aldehyde Dehydrogenase (ALDH)	Cancer
ALDH3A1-IN-3 (CB29) is a selective inhibitor of *ALDH3A1, with a K_i* value of 4.7 μM and an IC₅₀ value of 16 μM. ALDH3A1-IN-3 has no inhibitory potential on the in vitro activity of ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, or ALDH2. ALDH3A1-IN-3 can be used in cellular oxidation and cancer research ^[1].

HY-159111

KS124	Aldehyde Dehydrogenase (ALDH) Apoptosis Reactive Oxygen Species	Cancer
KS124 (compound 3) is a potent *ALDH* inhibitor. KS124 shows inhibition for *ALDH1A1, ALDH1A3, ALDH3A1. KS124 shows antiproliferative activity. KS124 induces apoptosis* and ROS production ^[1].

HY-112278

NCT-506	Aldehyde Dehydrogenase (ALDH)	Cancer
NCT-506 is an orally bioavailable aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with an IC₅₀ of 7 nM ^[1].

HY-110294

CM037 A37	Aldehyde Dehydrogenase (ALDH)	Cancer
CM037 is a selective inhibitor of *ALDH1A1* (aldehyde dehydrogenase 1A1) with an IC₅₀ of 4.6 µM ^[1].

HY-129314

CM-39	Aldehyde Dehydrogenase (ALDH)	Cancer
CM-39 is a non-covalent and reversible inhibitor for aldehyde dehydrogenase 1A (ALDH1A) with an IC₅₀ of 0.9 μM ^[1].

HY-139032

CM121	Aldehyde Dehydrogenase (ALDH)	Others
CM121 is an active site-directed reversible *ALDH1A2* inhibitor (IC₅₀=0.54 μM；Kd=1.1 μM) with a variety of hydrophobic interactions ^[1].

HY-148466

IGUANA-1	Aldehyde Dehydrogenase (ALDH)	Cancer
IGUANA-1 is a potent inhibitor of *ALDH1B1, which is a mitochondrial enzyme that promotes colorectal and pancreatic cancer. IGUANA*-1 has significant inhibition against cancer cells ^[1].

HY-N7083

Citral 1 Publications Verification	Apoptosis Aldehyde Dehydrogenase (ALDH)	Inflammation/Immunology Cancer
Citral is an orally active monoterpene compound in lemon grass essential oil and a natural ALDH1A inhibitor, which can induce apoptosis and cycle arrest in breast cancer cell lines, and has analgesic, anti-injurious and anti-inflammatory effects ^[2][3].

HY-112277

NCT-505	Aldehyde Dehydrogenase (ALDH)	Cancer
NCT-505 is a potent and selective aldehyde dehydrogenase (ALDH1A1) inhibitor, with an IC₅₀ of 7 nM, and weakly inhibits hALDH1A2, hALDH1A3, hALDH2, hALDH3A1 (IC₅₀s, >57, 22.8, 20.1, >57 μM).

HY-W011094

Win 18446 1 Publications Verification	Aldehyde Dehydrogenase (ALDH)	Endocrinology
Win 18446 is an orally active testes-specific enzyme ALDH1a2 inhibitor, with an IC₅₀ of 0.3 μM. Win 18446 reversibly inhibits spermatogenesis in many species and inhibits Retinoic acid (HY-14649) biosynthesis from Retinol (HY-B1342) within the testes ^[1] .

HY-W015273A

trans-3-Indoleacrylic acid	Endogenous Metabolite Ferroptosis	Metabolic Disease Cancer
Trans-3-Indoleacrylic acid is a tryptophan metabolite, which promotes tumor development through inhibition of RSL3 (HY-100218A) induced ferroptosis via AHR-ALDH1A3-FSP1-CoQ10 axis, and facilitates colorectal carcinogenesis ^[1]

HY-18768

NCT-501 4 Publications Verification	Aldehyde Dehydrogenase (ALDH)	Cancer
NCT-501 is a potent and selective theophylline-based inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1), inhibits hALDH1A1 with IC₅₀ of 40 nM, typically shows better selectivity over other ALDH isozymes and other dehydrogenases (hALDH1B1, hALDH3A1, and hALDH2, IC₅₀ >57 μM).

HY-N7083R

Citral (Standard)	Apoptosis Aldehyde Dehydrogenase (ALDH)	Inflammation/Immunology Cancer
Citral (Standard) is the analytical standard of Citral. This product is intended for research and analytical applications. Citral is an orally active monoterpene compound in lemon grass essential oil and a natural ALDH1A inhibitor, which can induce apoptosis and cycle arrest in breast cancer cell lines, and has analgesic, anti-injurious and anti-inflammatory effects .

HY-18768A

NCT-501 hydrochloride	Aldehyde Dehydrogenase (ALDH)	Cancer
NCT-501 hydrochloride is a potent and selective theophylline-based inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1), inhibits hALDH1A1 with IC₅₀ of 40 nM, typically shows better selectivity over other ALDH isozymes and other dehydrogenases (hALDH1B1, hALDH3A1, and hALDH2, IC₅₀ >57 μM) ^[1] .

HY-146683

KS106	Aldehyde Dehydrogenase (ALDH) Apoptosis	Cancer
KS106 is a potent *ALDH* inhibitor with IC₅₀s of 334, 2137, 360 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS106 induces apoptosis and cell cycle arrest at the G2/M phase ^[1].

HY-146682

KS100	Aldehyde Dehydrogenase (ALDH) Apoptosis	Cancer
KS100 is a potent *ALDH* inhibitor with IC₅₀s of 230, 1542, 193 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS100 shows antiproliferative and anticancer effects with low low toxic. KS100 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS10600 induces apoptosis and cell cycle arrest at the G2/M phase ^[1].

HY-138097

α-NETA 5+ Cited Publications	Chemerin Receptor Aldehyde Dehydrogenase (ALDH) Cholinesterase (ChE) Apoptosis	Cancer
α-NETA is a potent and noncompetitive choline acetyltransferase (ChA) inhibitor with an IC₅₀ of 9 μM. α-NETA is a potent ALDH1A1 (IC₅₀=0.04 µM) and chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA weakly inhibits cholinesterase (ChE; IC₅₀=84 µM) and acetylcholinesterase (AChE; IC₅₀=300 µM). α-NETA has anti-cancer activity ^[1] .

HY-155816

PROTAC NSD3 degrader-1	PROTACs	Cancer
PROTAC NSD3 degrader-1 (compound 56) is a PROTAC targeting to Nuclear receptor binding SET domain protein NSD3. PROTAC NSD3 degrader-1 specifically induces NSD3 degradation with DC50 values of 1.43 and 0.94 μM in lung cancer cells NCI-H1703 and A549, respectively. PROTAC NSD3 degrader-1 suppresses the methylation of H3K36, induces apoptosis, and causes cell-cycle arrest. PROTAC NSD3 degrader-1 also downregulates the expression of NSD3-associated genes such as CDC25A, ALDH1A1, and IGFBP.

Citral 1 Publications Verification	Structural Classification Microorganisms Classification of Application Fields Cymbopogon citratus Ketones, Aldehydes, Acids Gramineae Source classification Plants Disease Research Fields Biological Pesticide Research Cancer Agricultural Research	Apoptosis Aldehyde Dehydrogenase (ALDH)
Citral is an orally active monoterpene compound in lemon grass essential oil and a natural ALDH1A inhibitor, which can induce apoptosis and cycle arrest in breast cancer cell lines, and has analgesic, anti-injurious and anti-inflammatory effects ^[2][3].

trans-3-Indoleacrylic acid	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite Ferroptosis
Trans-3-Indoleacrylic acid is a tryptophan metabolite, which promotes tumor development through inhibition of RSL3 (HY-100218A) induced ferroptosis via AHR-ALDH1A3-FSP1-CoQ10 axis, and facilitates colorectal carcinogenesis ^[1]

Citral (Standard)	Structural Classification Microorganisms Cymbopogon citratus Ketones, Aldehydes, Acids Gramineae Source classification Plants	Apoptosis Aldehyde Dehydrogenase (ALDH)
Citral (Standard) is the analytical standard of Citral. This product is intended for research and analytical applications. Citral is an orally active monoterpene compound in lemon grass essential oil and a natural ALDH1A inhibitor, which can induce apoptosis and cycle arrest in breast cancer cell lines, and has analgesic, anti-injurious and anti-inflammatory effects .

Species:	Human (4)
Tag:	His (4)
Source:	P. pastoris (1) E. coli (3)

Cat. No.	Compare	Product Name	Species	Source

HY-P7474

	ALDH1A1 Protein, Human (His) rHuAldehyde Dehydrogenase 1-A1, His; ALDH-1A1; Aldehyde Dehydrogenase 1-A1	Human	E. coli
	ALDH1A1 Protein, Human (His) is a human recombinant ALDH1A1 with an N-terminal Met and His tag produced in E. coli. ALDH1A1 Protein, Human (His) contains 501 amino acids (1-501 a.a.).

HY-P7475

	ALDH1A2 Protein, Human (His) rHuAldehyde Dehydrogenase 1-A2, His ; ALDH-1A2; Aldehyde Dehydrogenase 1-A2	Human	E. coli
	ALDH1A2 Protein, Human (His) is a human recombinant ALDH1A2 with a N-terminal His tag produced in E. coli. ALDH1A2 Protein, Human (His) expresses the target gene encoding Met1-Ser518.

HY-P7476

	ALDH1A3 Protein, Human (His) rHuAldehyde Dehydrogenase 1-A3, His; ALDH-1A3; Aldehyde Dehydrogenase 1-A3	Human	E. coli
	ALDH1A3 Protein, Human (His) is a human recombinant ALDH1A3 with a His tag at the N-terminus. ALDH1A3 Protein, Human (His) is produced in E. coli and the target gene encoding Met1-Pro512 is expressed.

HY-P700646

	ALDH1A2 Protein, Human (P.pastoris, His) rHuAldehyde Dehydrogenase 1-A2, His ; ALDH-1A2; Aldehyde Dehydrogenase 1-A2	Human	P. pastoris
	The ALDH1A2 protein catalyzes the NAD-dependent oxidation of aldehyde substrates, including all-trans -retinal and all-trans 13,14-dihydroretinal. ALDH1A2 Protein, Human (P.pastoris, His) is the recombinant human-derived ALDH1A2 protein, expressed by P. pastoris , with N-6*His labeled tag. The total length of ALDH1A2 Protein, Human (P.pastoris, His) is 518 a.a., with molecular weight of 58.7 kDa.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80536

	ALDH1A1 Antibody ALDH1A1; ALDC; ALDH1; PUMB1; Retinal dehydrogenase 1; RALDH 1; RALDH1; ALDH-E1; ALHDII; Aldehyde dehydrogenase family 1 member A1; Aldehyde dehydrogenase; cytosolic	WB, IHC-P, IP	Human, Mouse
	ALDH1A1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to ALDH1A1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.

HY-P82286

	ALDH1L1 Antibody (YA2031) FDH; FTHFD; 10-fTHF; 10-FTHFDH	WB	Mouse, Rat
	ALDH1L1 Antibody (YA2031) is a biotin-conjugated non-conjugated IgG antibody, targeting ALDH1L1, with a predicted molecular weight of 99 kDa (observed band size: 99 kDa). ALDH1L1 Antibody (YA2031) can be used for WB experiment in mouse, rat background.

HY-P81724

	ALDH1A2 Antibody (YA1469) ALDH1A2; RALDH2; Retinal dehydrogenase 2; RALDH 2; RALDH2; Aldehyde dehydrogenase family 1 member A2; Retinaldehyde-specific dehydrogenase type 2; RALDH(II)	WB	Human, Mouse, Rat
	ALDH1A2 Antibody (YA1469) is a biotin-conjugated non-conjugated IgG antibody, targeting ALDH1A2, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). ALDH1A2 Antibody (YA1469) can be used for WB experiment in human, mouse, rat background.